Nonmelanoma Skin Cancer and Risk for Subsequent Malignancy-Reference-Cited by-同舟云学术

Nonmelanoma Skin Cancer and Risk for Subsequent Malignancy

Published:2008-08-26 Issue:17 Volume:100 Page:1215-1222
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Chen J.,Ruczinski I.,Jorgensen T. J.,Yenokyan G.,Yao Y.,Alani R.,Liegeois N. J.,Hoffman S. C.,Hoffman-Bolton J.,Strickland P. T.,Helzlsouer K. J.,Alberg A. J.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/100/17/1215/7682593/djn260.pdf

Reference28 articles.

1. Cost of Nonmelanoma Skin Cancer Treatment in the United States

2. Risk of Developing a Subsequent Nonmelanoma Skin Cancer in Patients With a History of Nonmelanoma Skin Cancer

3. Basal cell carcinoma

4. The risk and risk factors of a second non-melanoma skin cancer: a study in a Mediterranean population

5. Risk of Subsequent Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Among Patients With Prior Skin Cancer

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in skin cancer surveillance among patients with nonmelanoma skin cancer by race: A retrospective cohort study;Journal of the American Academy of Dermatology;2024-07

2. Common skin cancers and their association with other non-cutaneous primary malignancies: a review of the literature;Medical Oncology;2024-05-17

3. Melanoma and CLL co-occurrence and survival: role of KC history;BMC Cancer;2023-11-09

4. Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2023-11

5. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023;European Journal of Cancer;2023-10